group_name,group_level,strata_name,strata_level,variable,variable_level,variable_type,estimate_type,estimate,cdm_name
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number subjects,NA,NA,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number records,NA,NA,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,median,60,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,q25,49,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,q75,71.25,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,median,257,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,q25,70.5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,q75,437.75,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,median,749,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,q25,531.75,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,q75,1376.25,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,median,2021-10-30,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q25,2021-02-20,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q75,2022-03-03,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,median,2021-04-24,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q25,2020-11-25,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q75,2022-01-05,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,21.7391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,count,33,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,%,71.7391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,%,30.4347826086957,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,%,30.4347826086957,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,33,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,71.7391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,%,15.2173913043478,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,%,23.9130434782609,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,%,13.0434782608696,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,%,23.9130434782609,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,%,17.3913043478261,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,%,8.69565217391304,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,%,8.69565217391304,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,%,4.34782608695652,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,%,26.0869565217391,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,%,2.17391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,%,21.7391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,%,17.3913043478261,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,%,21.7391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,%,34.7826086956522,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,23.9130434782609,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,%,17.3913043478261,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,%,30.4347826086957,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,%,8.69565217391304,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,4.34782608695652,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,%,47.8260869565217,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,%,34.7826086956522,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,%,8.69565217391304,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,%,43.4782608695652,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,%,19.5652173913043,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,%,32.6086956521739,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,%,15.2173913043478,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,%,10.8695652173913,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,%,28.2608695652174,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,%,52.1739130434783,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,%,6.52173913043478,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,%,4.34782608695652,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,%,13.0434782608696,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,%,32.6086956521739,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,%,45.6521739130435,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,%,8.69565217391304,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,multiple,categorical,%,6.52173913043478,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,none,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,none,categorical,%,45.6521739130435,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,%,45.6521739130435,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,sle,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,sle,categorical,%,2.17391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Female,categorical,count,36,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Female,categorical,%,78.2608695652174,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Male,categorical,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Male,categorical,%,21.7391304347826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number subjects,NA,NA,count,61,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number records,NA,NA,count,61,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,median,58,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,q25,49,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,q75,68,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,median,655,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,q25,242.5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,q75,988,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,q75,909.5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,median,2019-10-22,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,q25,2019-06-13,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,q75,2020-03-02,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,median,2019-04-03,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,q25,2019-01-01,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,q75,2019-09-17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,24.5901639344262,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,count,33,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,%,54.0983606557377,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,%,36.0655737704918,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,%,18.0327868852459,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,49,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,80.327868852459,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,count,61,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,%,8.19672131147541,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,%,26.2295081967213,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,%,14.7540983606557,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,%,19.672131147541,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,%,11.4754098360656,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,%,6.55737704918033,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,%,6.55737704918033,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,%,3.27868852459016,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,%,3.27868852459016,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,%,1.63934426229508,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,%,24.5901639344262,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,%,11.4754098360656,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,%,13.1147540983607,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,%,34.4262295081967,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,14.7540983606557,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,%,9.83606557377049,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,%,32.7868852459016,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,%,4.91803278688525,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,11.4754098360656,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,%,49.1803278688525,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,%,24.5901639344262,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,count,61,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,%,3.27868852459016,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,%,22.9508196721311,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,%,16.3934426229508,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,%,1.63934426229508,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,%,19.672131147541,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,%,11.4754098360656,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,%,9.83606557377049,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,%,13.1147540983607,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,%,3.27868852459016,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,%,52.4590163934426,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,%,1.63934426229508,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,%,1.63934426229508,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,20 to 39,categorical,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,20 to 39,categorical,%,11.4754098360656,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,40 to 59,categorical,count,28,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,40 to 59,categorical,%,45.9016393442623,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,60 to 79,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,60 to 79,categorical,%,34.4262295081967,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,80 to 150,categorical,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,80 to 150,categorical,%,8.19672131147541,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,multiple,categorical,%,3.27868852459016,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,none,categorical,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,none,categorical,%,44.2622950819672,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,%,49.1803278688525,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,sle,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,sle,categorical,%,3.27868852459016,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Female,categorical,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Female,categorical,%,75.4098360655738,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Male,categorical,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Male,categorical,%,24.5901639344262,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,before_pandemic,categorical,count,61,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,before_pandemic,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number subjects,NA,NA,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number records,NA,NA,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,median,58,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q25,42,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q75,71,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,median,689,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q25,262,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q75,778,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,median,1144,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q25,711,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q75,1167,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,median,2020-07-14,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q25,2020-05-23,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q75,2020-08-16,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,median,2020-03-23,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q25,2020-03-01,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q75,2020-04-20,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,17.6470588235294,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,%,47.0588235294118,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,%,35.2941176470588,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,64.7058823529412,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,%,29.4117647058824,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,%,35.2941176470588,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,%,17.6470588235294,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,%,17.6470588235294,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,17.6470588235294,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,%,47.0588235294118,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,64.7058823529412,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,%,5.88235294117647,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,%,17.6470588235294,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,%,41.1764705882353,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,%,11.7647058823529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,none,categorical,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,none,categorical,%,35.2941176470588,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,%,52.9411764705882,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,count,13,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,%,76.4705882352941,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,%,23.5294117647059,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number subjects,NA,NA,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number records,NA,NA,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,median,54,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,q25,42.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,q75,58,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,median,117,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,q25,71.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,q75,329,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,median,805,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,q25,547,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,q75,1155.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,median,2020-08-16,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,q25,2020-03-03,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,q75,2021-08-17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,median,2020-03-13,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,q25,2019-10-09,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,q75,2021-06-09,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,%,85.7142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antidepressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antidepressants_m365_to_0,NA,binary,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiepileptics_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiepileptics_m365_to_0,NA,binary,%,71.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antithrombotics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antithrombotics_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,anxiety_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,anxiety_minf_to_0,NA,binary,%,71.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,asthma_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,asthma_minf_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,copd_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,covid_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diabetes_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diabetes_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diuretics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diuretics_m365_to_0,NA,binary,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,%,71.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,gerd_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,gerd_minf_to_0,NA,binary,%,71.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,heart_failure_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypertension_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypertension_minf_to_0,NA,binary,%,85.7142857142857,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,immunosupressants_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,opioids_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,opioids_m365_to_0,NA,binary,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,osteoporosis_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,pneumonia_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psycholeptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psycholeptics_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psychostimulants_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,stroke_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,20 to 39,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,40 to 59,categorical,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,40 to 59,categorical,%,71.4285714285714,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,60 to 79,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,60 to 79,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,80 to 150,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,80 to 150,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,multiple,categorical,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,multiple,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Female,categorical,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Female,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Male,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Male,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,after_fda_retraction,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,after_fda_retraction,categorical,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,before_pandemic,categorical,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,during_hcq_use_for_covid,categorical,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number subjects,NA,NA,count,54,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number records,NA,NA,count,54,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,median,57.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,q25,41.25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,q75,68.75,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,median,485.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,q25,175.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,q75,826.25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,median,879.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,q75,1217.75,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,median,2020-07-13,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,q25,2019-12-09,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,q75,2021-07-05,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,median,2020-02-02,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,q25,2019-06-22,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,q75,2021-02-11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,27.7777777777778,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,count,37,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,%,68.5185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antidepressants_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antidepressants_m365_to_0,NA,binary,%,27.7777777777778,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiepileptics_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiepileptics_m365_to_0,NA,binary,%,25.9259259259259,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,42,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,77.7777777777778,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,count,54,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antithrombotics_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antithrombotics_m365_to_0,NA,binary,%,9.25925925925926,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,anxiety_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,anxiety_minf_to_0,NA,binary,%,27.7777777777778,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,asthma_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,asthma_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,%,22.2222222222222,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,%,11.1111111111111,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,%,1.85185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,%,1.85185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,copd_minf_to_0,NA,binary,%,5.55555555555556,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,covid_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,covid_minf_to_0,NA,binary,%,20.3703703703704,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,dementia_minf_to_0,NA,binary,%,1.85185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,depressive_disorder_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,depressive_disorder_minf_to_0,NA,binary,%,25.9259259259259,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diabetes_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diabetes_minf_to_0,NA,binary,%,12.962962962963,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diuretics_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diuretics_m365_to_0,NA,binary,%,12.962962962963,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,14.8148148148148,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,%,11.1111111111111,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,gerd_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,gerd_minf_to_0,NA,binary,%,31.4814814814815,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,heart_failure_minf_to_0,NA,binary,%,3.7037037037037,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,14.8148148148148,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypertension_minf_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypertension_minf_to_0,NA,binary,%,42.5925925925926,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypothyroidism_minf_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypothyroidism_minf_to_0,NA,binary,%,24.0740740740741,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,immunosupressants_m365_to_0,NA,binary,count,54,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,infertility_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,infertility_minf_to_0,NA,binary,%,1.85185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,%,7.40740740740741,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,%,31.4814814814815,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,%,24.0740740740741,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,opioids_m365_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,opioids_m365_to_0,NA,binary,%,22.2222222222222,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,osteoporosis_minf_to_0,NA,binary,%,3.7037037037037,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,pneumonia_minf_to_0,NA,binary,%,7.40740740740741,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psycholeptics_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psycholeptics_m365_to_0,NA,binary,%,20.3703703703704,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psychostimulants_m365_to_0,NA,binary,%,1.85185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,stroke_minf_to_0,NA,binary,%,5.55555555555556,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,%,3.7037037037037,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,0 to 19,categorical,%,1.85185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,20 to 39,categorical,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,20 to 39,categorical,%,18.5185185185185,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,40 to 59,categorical,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,40 to 59,categorical,%,37.037037037037,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,60 to 79,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,60 to 79,categorical,%,38.8888888888889,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,80 to 150,categorical,%,3.7037037037037,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,none,categorical,count,54,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,none,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Female,categorical,count,39,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Female,categorical,%,72.2222222222222,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Male,categorical,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Male,categorical,%,27.7777777777778,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,after_fda_retraction,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,after_fda_retraction,categorical,%,38.8888888888889,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,before_pandemic,categorical,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,before_pandemic,categorical,%,50,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,during_hcq_use_for_covid,categorical,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,during_hcq_use_for_covid,categorical,%,11.1111111111111,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number subjects,NA,NA,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number records,NA,NA,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,median,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,q25,53,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,q75,72.25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,median,364,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q25,232.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q75,779.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q25,701.75,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q75,942.75,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,median,2020-07-13,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q25,2019-09-27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q75,2021-05-20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,median,2020-01-29,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q25,2019-01-01,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q75,2020-12-21,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,18.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,%,48.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,%,18.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,42,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,70,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,%,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,%,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,%,6.66666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,%,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,%,13.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,%,11.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,%,11.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,%,3.33333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,%,13.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,%,1.66666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,%,18.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,%,13.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,%,26.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,%,8.33333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,3.33333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,count,31,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,%,51.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,%,35,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.66666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,%,28.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,%,13.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,%,1.66666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,%,23.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,%,18.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,%,11.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,%,1.66666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,%,6.66666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,count,24,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,%,40,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,count,23,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,%,38.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,%,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Female,categorical,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Female,categorical,%,76.6666666666667,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Male,categorical,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Male,categorical,%,23.3333333333333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,%,35,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,%,50,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,%,15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,number subjects,NA,NA,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,number records,NA,NA,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,future_observation,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,future_observation,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,future_observation,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,prior_history,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,prior_history,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,prior_history,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,cohort_end_date,NA,date,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,cohort_end_date,NA,date,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,cohort_end_date,NA,date,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,cohort_start_date,NA,date,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,cohort_start_date,NA,date,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,cohort_start_date,NA,date,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antibacterials_systemic_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antibacterials_systemic_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antidepressants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antidepressants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antiepileptics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antiepileptics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antineoplastic_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antineoplastic_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antithrombotics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,antithrombotics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,anxiety_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,anxiety_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,asthma_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,asthma_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,beta_blocking_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,beta_blocking_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,calicum_channel_blockers_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,calicum_channel_blockers_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,chronic_kidney_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,chronic_kidney_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,chronic_liver_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,chronic_liver_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,copd_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,copd_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,covid_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,covid_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,dementia_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,dementia_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,depressive_disorder_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,depressive_disorder_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,diabetes_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,diabetes_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,diuretics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,diuretics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,drugs_acid_related_disorder_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,drugs_acid_related_disorder_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,drugs_used_in_diabetes_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,drugs_used_in_diabetes_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,gerd_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,gerd_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,heart_failure_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,heart_failure_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hiv_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hiv_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hypertension_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hypertension_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hypothyroidism_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,hypothyroidism_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,immunosupressants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,immunosupressants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,infertility_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,infertility_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,inflammatory_bowel_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,inflammatory_bowel_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,lipid_modifying_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,lipid_modifying_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,malaria_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,malaria_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,malignant_neoplastic_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,malignant_neoplastic_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,myocardial_infarction_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,myocardial_infarction_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,number_visits,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,number_visits,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,number_visits,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,opioids_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,opioids_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,osteoporosis_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,osteoporosis_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,pneumonia_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,pneumonia_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,psycholeptics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,psycholeptics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,psychostimulants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,psychostimulants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,rheumatoid_arthritis_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,rheumatoid_arthritis_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,stroke_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,stroke_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,venous_thromboembolism_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,venous_thromboembolism_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,20 to 39,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,20 to 39,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,40 to 59,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,40 to 59,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,60 to 79,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,60 to 79,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,80 to 150,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,80 to 150,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,0 to 19,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,age_group,0 to 19,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,sle,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,sle,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,none,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,none,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,rheumatoid_arthritis,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,rheumatoid_arthritis,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,multiple,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,indication,multiple,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,sex,Female,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,sex,Female,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,sex,Male,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,sex,Male,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,window,after_fda_retraction,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,window,after_fda_retraction,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,window,before_pandemic,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,window,before_pandemic,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,window,during_hcq_use_for_covid,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,sle,window,during_hcq_use_for_covid,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number subjects,NA,NA,count,124,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number records,NA,NA,count,124,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,median,58.5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,q25,49,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,q75,69,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,median,397,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,q25,173.5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,q75,779.5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,median,739,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,q25,675.75,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,q75,1068,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,median,2020-07-13,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,q25,2019-11-05,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,q75,2021-06-04,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,median,2020-02-07,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,q25,2019-04-04,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,q75,2021-01-03,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,22.5806451612903,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,count,74,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,%,59.6774193548387,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antidepressants_m365_to_0,NA,binary,count,40,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antidepressants_m365_to_0,NA,binary,%,32.258064516129,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiepileptics_m365_to_0,NA,binary,count,31,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiepileptics_m365_to_0,NA,binary,%,25,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,93,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,75,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,count,124,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antithrombotics_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antithrombotics_m365_to_0,NA,binary,%,10.4838709677419,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,anxiety_minf_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,anxiety_minf_to_0,NA,binary,%,25.8064516129032,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,asthma_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,asthma_minf_to_0,NA,binary,%,13.7096774193548,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,%,21.7741935483871,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,%,12.9032258064516,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,%,7.25806451612903,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,%,7.25806451612903,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,copd_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,copd_minf_to_0,NA,binary,%,4.83870967741935,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,covid_minf_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,covid_minf_to_0,NA,binary,%,16.1290322580645,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,dementia_minf_to_0,NA,binary,%,1.61290322580645,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,%,22.5806451612903,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diabetes_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diabetes_minf_to_0,NA,binary,%,13.7096774193548,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diuretics_m365_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diuretics_m365_to_0,NA,binary,%,16.9354838709677,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,count,40,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,%,32.258064516129,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,19.3548387096774,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,%,12.9032258064516,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,gerd_minf_to_0,NA,binary,count,38,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,gerd_minf_to_0,NA,binary,%,30.6451612903226,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,heart_failure_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,heart_failure_minf_to_0,NA,binary,%,7.25806451612903,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,8.87096774193548,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypertension_minf_to_0,NA,binary,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypertension_minf_to_0,NA,binary,%,48.3870967741936,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,count,35,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,%,28.2258064516129,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,immunosupressants_m365_to_0,NA,binary,count,124,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,infertility_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,infertility_minf_to_0,NA,binary,%,0.806451612903226,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.83870967741935,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,count,36,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,%,29.0322580645161,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,%,16.9354838709677,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,%,0.806451612903226,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,opioids_m365_to_0,NA,binary,count,31,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,opioids_m365_to_0,NA,binary,%,25,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,osteoporosis_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,osteoporosis_minf_to_0,NA,binary,%,12.0967741935484,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,pneumonia_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,pneumonia_minf_to_0,NA,binary,%,9.67741935483871,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psycholeptics_m365_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psycholeptics_m365_to_0,NA,binary,%,18.5483870967742,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psychostimulants_m365_to_0,NA,binary,%,1.61290322580645,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,count,67,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,%,54.0322580645161,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,stroke_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,stroke_minf_to_0,NA,binary,%,4.03225806451613,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,%,2.41935483870968,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,0 to 19,categorical,%,0.806451612903226,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,20 to 39,categorical,count,16,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,20 to 39,categorical,%,12.9032258064516,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,40 to 59,categorical,count,50,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,40 to 59,categorical,%,40.3225806451613,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,60 to 79,categorical,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,60 to 79,categorical,%,37.0967741935484,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,80 to 150,categorical,count,11,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,80 to 150,categorical,%,8.87096774193548,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,multiple,categorical,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,multiple,categorical,%,5.64516129032258,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,none,categorical,count,54,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,none,categorical,%,43.5483870967742,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,rheumatoid_arthritis,categorical,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,rheumatoid_arthritis,categorical,%,48.3870967741936,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,sle,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,sle,categorical,%,2.41935483870968,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Female,categorical,count,95,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Female,categorical,%,76.6129032258064,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Male,categorical,count,29,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Male,categorical,%,23.3870967741935,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,after_fda_retraction,categorical,count,46,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,after_fda_retraction,categorical,%,37.0967741935484,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,before_pandemic,categorical,count,61,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,before_pandemic,categorical,%,49.1935483870968,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,during_hcq_use_for_covid,categorical,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,during_hcq_use_for_covid,categorical,%,13.7096774193548,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number subjects,NA,NA,count,73,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number records,NA,NA,count,73,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,median,55,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,q75,64,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,median,210,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,q25,108,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,q75,365,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,median,1179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,q25,584,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,q75,1486,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,median,2021-10-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q25,2021-04-24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q75,2022-03-12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,median,2021-06-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q25,2021-01-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q75,2021-11-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,23.2876712328767,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,count,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,%,68.4931506849315,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,%,39.7260273972603,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,%,23.2876712328767,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,57,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,78.0821917808219,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,%,17.8082191780822,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,%,9.58904109589041,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,%,32.8767123287671,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,%,19.1780821917808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,%,19.1780821917808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,%,17.8082191780822,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,%,16.4383561643836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,%,16.4383561643836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,%,10.958904109589,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,%,36.986301369863,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,%,21.9178082191781,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,%,20.5479452054795,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,%,21.9178082191781,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,%,26.027397260274,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,31.5068493150685,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,%,17.8082191780822,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,%,30.1369863013699,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,%,4.10958904109589,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,10.958904109589,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,count,33,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,%,45.2054794520548,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,%,27.3972602739726,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,%,23.2876712328767,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,%,5.47945205479452,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,%,31.5068493150685,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,%,12.3287671232877,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,%,28.7671232876712,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,%,5.47945205479452,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,%,5.47945205479452,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,%,31.5068493150685,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,%,1.36986301369863,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,%,26.027397260274,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,%,8.21917808219178,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,%,2.73972602739726,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,%,15.0684931506849,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,count,38,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,%,52.0547945205479,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,count,21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,%,28.7671232876712,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,%,4.10958904109589,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,covid,categorical,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,covid,categorical,%,6.84931506849315,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,multiple,categorical,%,5.47945205479452,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,none,categorical,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,none,categorical,%,56.1643835616438,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,%,20.5479452054795,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,sle,categorical,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,sle,categorical,%,10.958904109589,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Female,categorical,count,52,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Female,categorical,%,71.2328767123288,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Male,categorical,count,21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Male,categorical,%,28.7671232876712,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,count,73,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number subjects,NA,NA,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number records,NA,NA,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,q25,49,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,q75,69,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,median,847,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,q25,283.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,q75,1019.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,q75,863.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,median,2019-09-21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,q25,2019-04-12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,q75,2020-02-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,median,2019-01-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,q25,2019-01-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,q75,2019-07-05,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,38.9830508474576,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,count,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,%,57.6271186440678,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,%,47.4576271186441,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,%,32.2033898305085,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,69.4915254237288,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,%,23.728813559322,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,%,11.864406779661,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,%,37.2881355932203,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,%,13.5593220338983,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,%,32.2033898305085,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,%,22.0338983050847,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,%,18.6440677966102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,%,18.6440677966102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,%,8.47457627118644,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,%,6.77966101694915,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,%,30.5084745762712,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,%,18.6440677966102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,%,28.8135593220339,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,%,33.8983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,37.2881355932203,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,%,15.2542372881356,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,%,37.2881355932203,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,10.1694915254237,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,count,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,%,57.6271186440678,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,%,28.8135593220339,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,%,30.5084745762712,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,%,33.8983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,%,25.4237288135593,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,%,13.5593220338983,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,%,5.08474576271186,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,%,30.5084745762712,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,%,37.2881355932203,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,%,1.69491525423729,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,20 to 39,categorical,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,20 to 39,categorical,%,11.864406779661,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,40 to 59,categorical,count,27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,40 to 59,categorical,%,45.7627118644068,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,60 to 79,categorical,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,60 to 79,categorical,%,37.2881355932203,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,80 to 150,categorical,%,5.08474576271186,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,multiple,categorical,%,3.38983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,none,categorical,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,none,categorical,%,37.2881355932203,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,count,20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,%,33.8983050847458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,sle,categorical,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,sle,categorical,%,25.4237288135593,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Female,categorical,count,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Female,categorical,%,84.7457627118644,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Male,categorical,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Male,categorical,%,15.2542372881356,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,before_pandemic,categorical,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,before_pandemic,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number subjects,NA,NA,count,39,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number records,NA,NA,count,39,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,median,57,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q25,45.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q75,63.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,median,729,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q25,619.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q75,742,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,median,1173,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q25,914.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q75,1176.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,median,2020-05-09,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q25,2020-04-09,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q75,2020-06-15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,median,2020-03-21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q25,2020-03-19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q75,2020-04-06,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,23.0769230769231,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,%,17.9487179487179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,%,12.8205128205128,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,61.5384615384615,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,%,17.9487179487179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,%,7.69230769230769,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,%,20.5128205128205,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,%,15.3846153846154,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,%,7.69230769230769,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,%,15.3846153846154,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,%,5.12820512820513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,%,7.69230769230769,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,%,10.2564102564103,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,%,2.56410256410256,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,%,15.3846153846154,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,25.6410256410256,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,41.025641025641,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,2.56410256410256,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,%,28.2051282051282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,%,5.12820512820513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,2.56410256410256,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,%,41.025641025641,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,%,23.0769230769231,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,%,12.8205128205128,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,%,28.2051282051282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,17.9487179487179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,%,2.56410256410256,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,%,10.2564102564103,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,%,5.12820512820513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,%,15.3846153846154,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,%,17.9487179487179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,%,2.56410256410256,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,17.9487179487179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,%,5.12820512820513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,%,12.8205128205128,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,%,43.5897435897436,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,%,5.12820512820513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,%,2.56410256410256,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,none,categorical,count,25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,none,categorical,%,64.1025641025641,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,%,17.9487179487179,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,sle,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,sle,categorical,%,15.3846153846154,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,%,58.974358974359,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,%,41.025641025641,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,count,39,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number subjects,NA,NA,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number records,NA,NA,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,median,47,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,q25,40.75,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,q75,49.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,median,241,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,q25,133.75,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,q75,343,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,median,1325,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,q25,1175.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,q75,1524.75,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,median,2021-02-15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,q25,2020-09-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,q75,2021-10-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,median,2021-02-12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,q25,2020-08-25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,q75,2021-10-10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,%,83.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antidepressants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antidepressants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiepileptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiepileptics_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,83.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antithrombotics_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antithrombotics_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,anxiety_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,anxiety_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,asthma_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,asthma_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,copd_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,copd_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,covid_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,covid_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,depressive_disorder_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,depressive_disorder_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diabetes_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diabetes_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diuretics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diuretics_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,gerd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,gerd_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,heart_failure_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypertension_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypertension_minf_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypothyroidism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypothyroidism_minf_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,immunosupressants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,immunosupressants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,opioids_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,opioids_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,osteoporosis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,osteoporosis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,pneumonia_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psycholeptics_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psycholeptics_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,stroke_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,stroke_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,20 to 39,categorical,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,40 to 59,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,40 to 59,categorical,%,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,60 to 79,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,60 to 79,categorical,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,80 to 150,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,80 to 150,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,covid,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Female,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Female,categorical,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Male,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Male,categorical,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,after_fda_retraction,categorical,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,after_fda_retraction,categorical,%,83.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,during_hcq_use_for_covid,categorical,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number subjects,NA,NA,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number records,NA,NA,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,median,53.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,q25,40.75,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,q75,68.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,median,394.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,q25,287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,q75,427,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,median,1014.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,q25,616.75,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,q75,1440,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,median,2021-06-19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,q25,2020-04-30,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,q75,2021-11-25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,median,2021-01-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,q25,2019-07-07,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,q75,2021-03-15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antidepressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antidepressants_m365_to_0,NA,binary,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiepileptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiepileptics_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antithrombotics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antithrombotics_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,anxiety_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,anxiety_minf_to_0,NA,binary,%,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,asthma_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,asthma_minf_to_0,NA,binary,%,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,copd_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,covid_minf_to_0,NA,binary,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diabetes_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diabetes_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diuretics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diuretics_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,%,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,gerd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,gerd_minf_to_0,NA,binary,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,heart_failure_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypertension_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypertension_minf_to_0,NA,binary,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,immunosupressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,immunosupressants_m365_to_0,NA,binary,%,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,opioids_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,opioids_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,osteoporosis_minf_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,pneumonia_minf_to_0,NA,binary,%,50,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psycholeptics_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psycholeptics_m365_to_0,NA,binary,%,83.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,stroke_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,20 to 39,categorical,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,40 to 59,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,40 to 59,categorical,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,60 to 79,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,60 to 79,categorical,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,80 to 150,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,80 to 150,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,multiple,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,multiple,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Female,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Female,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Male,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Male,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,after_fda_retraction,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,after_fda_retraction,categorical,%,66.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,before_pandemic,categorical,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number subjects,NA,NA,count,88,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number records,NA,NA,count,88,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,median,55,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,q75,64.25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,median,531,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,q25,156,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,q75,742,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,median,1153,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,q75,1330.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,median,2020-12-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,q25,2020-03-28,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,q75,2021-09-19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,median,2020-05-04,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,q25,2020-02-10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,q75,2021-05-22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,30.6818181818182,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,%,67.0454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antidepressants_m365_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antidepressants_m365_to_0,NA,binary,%,27.2727272727273,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiepileptics_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiepileptics_m365_to_0,NA,binary,%,17.0454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,58,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,65.9090909090909,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,%,10.2272727272727,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antithrombotics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antithrombotics_m365_to_0,NA,binary,%,3.40909090909091,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,anxiety_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,anxiety_minf_to_0,NA,binary,%,29.5454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,asthma_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,asthma_minf_to_0,NA,binary,%,13.6363636363636,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,%,12.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,%,12.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,%,7.95454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,%,7.95454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,copd_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,copd_minf_to_0,NA,binary,%,7.95454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,covid_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,covid_minf_to_0,NA,binary,%,18.1818181818182,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,depressive_disorder_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,depressive_disorder_minf_to_0,NA,binary,%,18.1818181818182,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diabetes_minf_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diabetes_minf_to_0,NA,binary,%,12.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diuretics_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diuretics_m365_to_0,NA,binary,%,15.9090909090909,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,%,19.3181818181818,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,29.5454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,%,9.09090909090909,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,gerd_minf_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,gerd_minf_to_0,NA,binary,%,30.6818181818182,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,heart_failure_minf_to_0,NA,binary,%,2.27272727272727,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,10.2272727272727,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypertension_minf_to_0,NA,binary,count,39,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypertension_minf_to_0,NA,binary,%,44.3181818181818,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypothyroidism_minf_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypothyroidism_minf_to_0,NA,binary,%,26.1363636363636,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,immunosupressants_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,immunosupressants_m365_to_0,NA,binary,%,11.3636363636364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,%,3.40909090909091,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,%,29.5454545454545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,%,14.7727272727273,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,myocardial_infarction_minf_to_0,NA,binary,%,1.13636363636364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,opioids_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,opioids_m365_to_0,NA,binary,%,11.3636363636364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,osteoporosis_minf_to_0,NA,binary,%,2.27272727272727,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,pneumonia_minf_to_0,NA,binary,%,2.27272727272727,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psycholeptics_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psycholeptics_m365_to_0,NA,binary,%,20.4545454545455,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psychostimulants_m365_to_0,NA,binary,%,3.40909090909091,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,stroke_minf_to_0,NA,binary,%,3.40909090909091,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,%,1.13636363636364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,0 to 19,categorical,%,2.27272727272727,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,20 to 39,categorical,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,20 to 39,categorical,%,13.6363636363636,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,40 to 59,categorical,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,40 to 59,categorical,%,46.5909090909091,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,60 to 79,categorical,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,60 to 79,categorical,%,32.9545454545455,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,80 to 150,categorical,%,4.54545454545455,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,none,categorical,count,88,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,none,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Female,categorical,count,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Female,categorical,%,61.3636363636364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Male,categorical,count,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Male,categorical,%,38.6363636363636,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,after_fda_retraction,categorical,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,after_fda_retraction,categorical,%,46.5909090909091,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,before_pandemic,categorical,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,before_pandemic,categorical,%,25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,during_hcq_use_for_covid,categorical,count,25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,during_hcq_use_for_covid,categorical,%,28.4090909090909,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number subjects,NA,NA,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number records,NA,NA,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,median,58,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,q25,51,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,q75,67.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,median,364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q25,202,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q75,652.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,median,757,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q25,691,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q75,1015.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,median,2020-06-15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q25,2019-09-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q75,2021-12-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,median,2020-02-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q25,2019-02-25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q75,2021-01-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,30.952380952381,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,%,61.9047619047619,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,%,54.7619047619048,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,%,35.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,35,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,83.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,%,40.4761904761905,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,%,9.52380952380952,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,%,11.9047619047619,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,%,23.8095238095238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,%,9.52380952380952,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,%,11.9047619047619,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,%,35.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,%,21.4285714285714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,%,30.952380952381,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,%,45.2380952380952,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,35.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,%,23.8095238095238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,%,38.0952380952381,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,%,2.38095238095238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,2.38095238095238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,%,52.3809523809524,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,%,35.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,%,7.14285714285714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,%,2.38095238095238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,%,33.3333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,%,9.52380952380952,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,%,26.1904761904762,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,%,2.38095238095238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,%,4.76190476190476,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,%,4.76190476190476,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,%,54.7619047619048,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,%,30.952380952381,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,%,9.52380952380952,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,sle,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,sle,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Female,categorical,count,36,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Female,categorical,%,85.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Male,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Male,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,%,35.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,count,20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,%,47.6190476190476,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,%,16.6666666666667,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,number subjects,NA,NA,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,number records,NA,NA,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age,NA,numeric,median,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age,NA,numeric,q25,43,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age,NA,numeric,q75,64,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,future_observation,NA,numeric,median,355,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,future_observation,NA,numeric,q25,150,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,future_observation,NA,numeric,q75,744,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,prior_history,NA,numeric,q25,535,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,prior_history,NA,numeric,q75,984,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,cohort_end_date,NA,date,median,2020-05-09,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,cohort_end_date,NA,date,q25,2019-10-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,cohort_end_date,NA,date,q75,2021-08-15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,cohort_start_date,NA,date,median,2019-09-17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,cohort_start_date,NA,date,q25,2019-02-24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,cohort_start_date,NA,date,q75,2021-03-19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,20.6896551724138,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antibacterials_systemic_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antibacterials_systemic_m365_to_0,NA,binary,%,48.2758620689655,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antidepressants_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antidepressants_m365_to_0,NA,binary,%,44.8275862068966,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antiepileptics_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antiepileptics_m365_to_0,NA,binary,%,27.5862068965517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,68.9655172413793,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antineoplastic_agents_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antineoplastic_agents_m365_to_0,NA,binary,%,20.6896551724138,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antithrombotics_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,antithrombotics_m365_to_0,NA,binary,%,27.5862068965517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,anxiety_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,anxiety_minf_to_0,NA,binary,%,41.3793103448276,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,asthma_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,asthma_minf_to_0,NA,binary,%,24.1379310344828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,beta_blocking_agents_m365_to_0,NA,binary,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,beta_blocking_agents_m365_to_0,NA,binary,%,37.9310344827586,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,calicum_channel_blockers_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,calicum_channel_blockers_m365_to_0,NA,binary,%,17.2413793103448,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,chronic_kidney_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,chronic_kidney_disease_minf_to_0,NA,binary,%,24.1379310344828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,chronic_liver_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,chronic_liver_disease_minf_to_0,NA,binary,%,24.1379310344828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,copd_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,copd_minf_to_0,NA,binary,%,10.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,covid_minf_to_0,NA,binary,%,10.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,depressive_disorder_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,depressive_disorder_minf_to_0,NA,binary,%,17.2413793103448,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,diabetes_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,diabetes_minf_to_0,NA,binary,%,17.2413793103448,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,diuretics_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,diuretics_m365_to_0,NA,binary,%,31.0344827586207,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,drugs_acid_related_disorder_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,drugs_acid_related_disorder_m365_to_0,NA,binary,%,31.0344827586207,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,44.8275862068966,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,drugs_used_in_diabetes_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,drugs_used_in_diabetes_m365_to_0,NA,binary,%,10.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,gerd_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,gerd_minf_to_0,NA,binary,%,24.1379310344828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,heart_failure_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,heart_failure_minf_to_0,NA,binary,%,6.89655172413793,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,13.7931034482759,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hypertension_minf_to_0,NA,binary,count,16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hypertension_minf_to_0,NA,binary,%,55.1724137931034,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hypothyroidism_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,hypothyroidism_minf_to_0,NA,binary,%,24.1379310344828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,immunosupressants_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,immunosupressants_m365_to_0,NA,binary,%,31.0344827586207,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,lipid_modifying_agents_m365_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,lipid_modifying_agents_m365_to_0,NA,binary,%,34.4827586206897,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,malignant_neoplastic_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,malignant_neoplastic_disease_minf_to_0,NA,binary,%,6.89655172413793,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,myocardial_infarction_minf_to_0,NA,binary,%,3.44827586206897,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,opioids_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,opioids_m365_to_0,NA,binary,%,31.0344827586207,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,osteoporosis_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,osteoporosis_minf_to_0,NA,binary,%,10.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,pneumonia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,pneumonia_minf_to_0,NA,binary,%,10.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,psycholeptics_m365_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,psycholeptics_m365_to_0,NA,binary,%,48.2758620689655,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,stroke_minf_to_0,NA,binary,%,10.3448275862069,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,venous_thromboembolism_minf_to_0,NA,binary,%,3.44827586206897,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,20 to 39,categorical,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,20 to 39,categorical,%,17.2413793103448,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,40 to 59,categorical,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,40 to 59,categorical,%,44.8275862068966,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,60 to 79,categorical,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,60 to 79,categorical,%,37.9310344827586,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,80 to 150,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,age_group,80 to 150,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,sle,categorical,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,sle,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,sex,Female,categorical,count,25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,sex,Female,categorical,%,86.2068965517241,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,sex,Male,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,sex,Male,categorical,%,13.7931034482759,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,window,after_fda_retraction,categorical,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,window,after_fda_retraction,categorical,%,27.5862068965517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,window,before_pandemic,categorical,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,window,before_pandemic,categorical,%,51.7241379310345,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,window,during_hcq_use_for_covid,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,sle,window,during_hcq_use_for_covid,categorical,%,20.6896551724138,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number subjects,NA,NA,count,171,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number records,NA,NA,count,171,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,q75,65,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,median,377,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,q25,158.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,q75,740,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,median,910,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,q75,1197,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,median,2020-10-02,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,q25,2020-01-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,q75,2021-09-24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,median,2020-04-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,q25,2019-06-22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,q75,2021-04-13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,49,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.6549707602339,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,count,110,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,%,64.327485380117,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antidepressants_m365_to_0,NA,binary,count,64,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antidepressants_m365_to_0,NA,binary,%,37.4269005847953,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiepileptics_m365_to_0,NA,binary,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiepileptics_m365_to_0,NA,binary,%,23.9766081871345,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,122,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,71.3450292397661,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,count,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,%,19.8830409356725,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antithrombotics_m365_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antithrombotics_m365_to_0,NA,binary,%,9.94152046783626,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,anxiety_minf_to_0,NA,binary,count,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,anxiety_minf_to_0,NA,binary,%,31.5789473684211,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,asthma_minf_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,asthma_minf_to_0,NA,binary,%,16.374269005848,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,count,36,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,%,21.0526315789474,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,%,18.7134502923977,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,%,13.4502923976608,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,%,13.4502923976608,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,copd_minf_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,copd_minf_to_0,NA,binary,%,8.7719298245614,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,covid_minf_to_0,NA,binary,count,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,covid_minf_to_0,NA,binary,%,19.8830409356725,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,count,38,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,%,22.2222222222222,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diabetes_minf_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diabetes_minf_to_0,NA,binary,%,15.7894736842105,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diuretics_m365_to_0,NA,binary,count,39,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diuretics_m365_to_0,NA,binary,%,22.8070175438597,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,count,49,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.6549707602339,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,61,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,35.672514619883,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.4502923976608,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,gerd_minf_to_0,NA,binary,count,55,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,gerd_minf_to_0,NA,binary,%,32.1637426900585,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,heart_failure_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,heart_failure_minf_to_0,NA,binary,%,4.09356725146199,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,8.7719298245614,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypertension_minf_to_0,NA,binary,count,83,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypertension_minf_to_0,NA,binary,%,48.5380116959064,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,count,46,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,%,26.9005847953216,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,immunosupressants_m365_to_0,NA,binary,count,40,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,immunosupressants_m365_to_0,NA,binary,%,23.3918128654971,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,%,2.33918128654971,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,count,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,%,31.5789473684211,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,%,10.5263157894737,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,%,1.75438596491228,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,opioids_m365_to_0,NA,binary,count,40,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,opioids_m365_to_0,NA,binary,%,23.3918128654971,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,osteoporosis_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,osteoporosis_minf_to_0,NA,binary,%,8.18713450292398,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,pneumonia_minf_to_0,NA,binary,count,13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,pneumonia_minf_to_0,NA,binary,%,7.60233918128655,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psycholeptics_m365_to_0,NA,binary,count,48,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psycholeptics_m365_to_0,NA,binary,%,28.0701754385965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psychostimulants_m365_to_0,NA,binary,%,2.33918128654971,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,count,48,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,%,28.0701754385965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,stroke_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,stroke_minf_to_0,NA,binary,%,4.09356725146199,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,%,2.33918128654971,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,0 to 19,categorical,%,1.16959064327485,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,20 to 39,categorical,count,23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,20 to 39,categorical,%,13.4502923976608,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,40 to 59,categorical,count,82,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,40 to 59,categorical,%,47.953216374269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,60 to 79,categorical,count,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,60 to 79,categorical,%,32.7485380116959,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,80 to 150,categorical,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,80 to 150,categorical,%,4.67836257309941,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,covid,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,covid,categorical,%,3.50877192982456,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,multiple,categorical,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,multiple,categorical,%,3.50877192982456,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,none,categorical,count,88,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,none,categorical,%,51.4619883040936,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,rheumatoid_arthritis,categorical,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,rheumatoid_arthritis,categorical,%,24.5614035087719,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,sle,categorical,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,sle,categorical,%,16.9590643274854,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Female,categorical,count,125,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Female,categorical,%,73.0994152046784,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Male,categorical,count,46,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Male,categorical,%,26.9005847953216,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,after_fda_retraction,categorical,count,73,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,after_fda_retraction,categorical,%,42.6900584795322,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,before_pandemic,categorical,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,before_pandemic,categorical,%,34.5029239766082,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,during_hcq_use_for_covid,categorical,count,39,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,during_hcq_use_for_covid,categorical,%,22.8070175438597,PHARMETRICS
